The U.S. Food and Drug Administration (FDA) recently granted accelerated approval to Global Blood Therapeutics’ voxelotor (Oxbryta), a treatment for adults and pediatric patients (12 years and older)…
Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.